Clinical manifestations of cardiovascular disease in children as a sequela of coronavirus disease (COVID-19) (a clinical case)
DOI:
https://doi.org/10.14739/2310-1210.2022.3.251076Keywords:
COVID-19, myocarditis, child, acute coronary syndrome, arrhythmiaAbstract
The aim of the work: to provide medical practitioners with a clinical case of cardiovascular affection with ST-segment elevation in a child as a result of coronavirus disease (COVID-19).
Materials and methods. Here is a clinical case of our own observation of the clinical course of post-COVID cardiovascular system involvement with ST-segment elevation in the child who was treated at the City Children’s Hospital No. 5 of Zaporizhzhia City Council.
Results. The patient with severe post-COVID cardiovascular implication, COVID in anamnesis confirmed by COVID-19 IgG positivity with negative IgM and PCR test results. The following laboratory findings were also detected when the child was admitted to the hospital: Troponin I was 136 ƞg /ml (referent value – less than 0.32 ƞg/ml), Lactate Dehydrogenase – 4199 U/l (referent value – 110–295), Creatine Phosphokinase-MB – 25.4 U/l (referent value – 0–24), CRP was increased to 6.2 mg/l, D-dimer – to 3221.12 ng/mL (referent value – less than 500 ng/mL). ECG showed QS-waves in leads V3–V6, I, 2.0–2.5 mm ST-segment elevation in leads V4–V6, and Р-mitrale.
The clinical course was characterized by cardiogenic shock development. During intensive care, there was moderate positive clinical and laboratory dynamics. Peculiarities of post-COVID myocarditis in children were characterized based on the comparative analysis of this clinical case and results of relevant clinical studies, world recommendations and guidelines.
Conclusions. Peculiarity of the case is severe post-COVID syndrome after almost asymptomatic COVID-19. Physicians should be aware after coronavirus disease while providing a close follow-up for six months. Myocardial ischemia is among casuistic post-COVID manifestations in children. The basic treatment is a complex therapy of heart failure, anticoagulant and antiplatelet therapy, as well as corticosteroids administration, which is pathogenetically justified and leads to regression of major clinical and laboratory symptoms.
References
Sperotto, F., Friedman, K. G., Son, M., VanderPluym, C. J., Newburger, J. W., & Dionne, A. (2021). Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. European Journal of Pediatrics, 180(2), 307-322. https://doi.org/10.1007/s00431-020-03766-6
Theocharis, P., Wong, J., Pushparajah, K., Mathur, S. K., Simpson, J. M., Pascall, E., Cleary, A., Stewart, K., Adhvaryu, K., Savis, A., Kabir, S. R., Uy, M. P., Heard, H., Peacock, K., & Miller, O. (2021). Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19. European Heart Journal - Cardiovascular Imaging, 22(8), 896-903. https://doi.org/10.1093/ehjci/jeaa212
Alsaied, T., Tremoulet, A. H., Burns, J. C., Saidi, A., Dionne, A., Lang, S. M., Newburger, J. W., de Ferranti, S., & Friedman, K. G. (2021). Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation, 143(1), 78-88. https://doi.org/10.1161/CIRCULATIONAHA.120.049836
Zbitnieva, V. O., Voloshyna, O. B., Balashova, I. V., Dukova, O. R., & Lysyi, I. S. (2021). Chastota vyiavlennia porushen sertsevoho rytmu v patsiientiv, yaki perenesly infektsiiu COVID-19, za danymy dobovoho monitoruvannia elektrokardiohramy [Incidence of cardiac arrhythmias in patients with COVID-19 infection according to 24-hour electrocardiogram monitoring]. Zaporozhye medical journal, 23(6), 759-765. https://doi.org/10.14739/2310-1210.2021.6.239243 [in Ukrainian].
Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O. (2020). Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiology, 5(7), 831-840. https://doi.org/10.1001/jamacardio.2020.1286
Blondiaux, E., Parisot, P., Redheuil, A., Tzaroukian, L., Levy, Y., Sileo, C., Schnuriger, A., Lorrot, M., Guedj, R., & Ducou le Pointe, H. (2020). Cardiac MRI in Children with Multisystem Inflammatory Syndrome Associated with COVID-19. Radiology, 297(3), E283-E288. https://doi.org/10.1148/radiol.2020202288
Regan, W., O'Byrne, L., Stewart, K., Miller, O., Pushparajah, K., Theocharis, P., Wong, J., & Rosenthal, E. (2021). Electrocardiographic Changes in Children with Multisystem Inflammation Associated with COVID-19: Associated with Coronavirus Disease 2019. The Journal of Pediatrics, 234, 27-32.E2. https://doi.org/10.1016/j.jpeds.2020.12.033
Buheruk, V. V., Vоlоshyna, O. B., & Balashova, I. V. (2021). Zapalne urazhennia miokardu u khvorykh na koronavirusnu khvorobu 2019 (COVID-19) [Inflammatory damage to the myocardium in patients with novel coronavirus disease (COVID-19)]. Zaporozhye medical journal, 23(4), 555-566. https://doi.org/10.14739/2310-1210.2021.4.211033 [in Ukrainian].
Toronchenko, O. M., Miakinkova, L. О., & Baklytskyi, D. D. (2021). Pomylky pid chas nadannia ekstrenoi medychnoi dopomohy patsiientam z EKH-oznakamy hostroho koronarnoho syndromu na tli dekompensatsii tsukrovoho diabetu z hiperkaliiemiieiu [Medical errors in providing emergency care to patients with ECG symptoms of acute coronary syndrome on the background of decompensation of diabetes mellitus with hyperkalemia]. Pathologia, 18(2), 243-250. https://doi.org/10.14739/2310-1237.2021.2.225044 [in Ukrainian].
Bejiqi, R., Retkoceri, R., Maloku, A., Mustafa, A., Bejiqi, H., & Bejiqi, R. (2019). The Diagnostic and Clinical Approach to Pediatric Myocarditis: A Review of the Current Literature. Open Access Macedonian Journal of Medical Sciences, 7(1), 162-173. https://doi.org/10.3889/oamjms.2019.010
Zhao, M., Wang, M., Zhang, J., Ye, J., Xu, Y., Wang, Z., Ye, D., Liu, J., & Wan, J. (2020). Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomedicine & Pharmacotherapy, 127, Article 110230. https://doi.org/10.1016/j.biopha.2020.110230
Dhakal, B. P., Sweitzer, N. K., Indik, J. H., Acharya, D., & William, P. (2020). SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart. Heart, Lung and Circulation, 29(7), 973-987. https://doi.org/10.1016/j.hlc.2020.05.101
Mehra, M. R., & Ruschitzka, F. (2020). COVID-19 Illness and Heart Failure: A Missing Link? JACC: Heart Failure, 8(6), 512-514. https://doi.org/10.1016/j.jchf.2020.03.004
Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., Bi, Z., & Zhao, Y. (2020). Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical Research in Cardiology, 109(5), 531-538. https://doi.org/10.1007/s00392-020-01626-9
Zheng, Y. Y., Ma, Y. T., Zhang, J. Y., & Xie, X. (2020). COVID-19 and the cardiovascular system. Nature Reviews Cardiology, 17(5), 259-260. https://doi.org/10.1038/s41569-020-0360-5
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
